Drug Type Small molecule drug |
Synonyms MK 8153, MK8153 |
Target |
Action blockers |
Mechanism Potassium channel blockers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H28N2O6 |
InChIKeyKDAIMYGCILCZSH-FQEVSTJZSA-N |
CAS Registry1548286-45-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscle Weakness | Preclinical | United States | 18 Sep 2021 | |
Heart Failure | Preclinical | United States | 26 May 2021 | |
Hypertension | Preclinical | United States | 26 May 2021 |